Upper Gastrointestinal Hemorrhage clinical trials at UCLA
1 research study open to eligible people
open to eligible people ages 18-100
The primary specific aim is to perform a randomized controlled trial (RCT) to compare 30 day rebleed rates and other clinical outcomes of patients with severe, non-variceal upper GI hemorrhage (NVUGIH) - ulcers and Dieulafoy's lesions who are randomized as initial treatment with the new large over-the-scope-clip device for endoscopic hemostasis versus standard endoscopic hemostasis.
Los Angeles, California and other locations
Our lead scientists for Upper Gastrointestinal Hemorrhage research studies include Dennis M Jensen, MD.